Taking care of patients and their communities is at the heart of what hospitals do, and that wouldn’t be possible without the clinical services that hospitals provide. These services touch all aspects of a hospital’s operations, ranging from the emergency department to behavioral health. Through its numerous area-specific groups, CHA provides advocacy and representation on all aspects of operations — guiding hospitals in meeting regulatory, legal, and licensing requirements.
About Clinical Care
Nonprofit organizations and counties that participate in the County Medical Services Program (CMSP) are encouraged to apply for funding through the Health Systems Development Grant Program.
The California Department of Public Health reminds general acute care hospitals and acute psychiatric hospitals that, effective Jan. 1, they may not require, as a condition of admission, a person who voluntarily seeks care to be placed on an involuntary hold under Section 5150 of the Welfare and Institutions Code.
The Emergency Medical Services Authority (EMSA) is in the process of updating its Statewide Trauma System Triage and Transfer Resource Guide. The draft guide incorporates feedback from a previous comment period in 2017. Due to the time elapsed since then, EMSA has offered another comment period.
Last week, CHA shared information about problems some providers have had in implementing a new state law requiring controlled substance security prescription forms to include a unique serial number. This week, the California Board of Pharmacy released updated frequently asked questions about the law’s requirements and enforcement.
As of Jan. 1, controlled substance security prescription forms must include a new, unique serial number in a format approved by the Department of Justice. However, the new requirement does not allow for a transition period during which providers would be allowed to use the previously approved form, and those who do not have access to the new forms have been forced to choose between denying care and risking action against their licenses.
Prescribers are now required to offer naloxone hydrochloride, or another drug approved by the Food and Drug Administration, to patients who experience certain conditions related to opioid depression. The Medical Board of California has released frequently asked questions to assist providers in implementing the new requirements, which took effect Jan. 1.
The Centers for Medicare & Medicaid Services (CMS) has issued a notice increasing fees for laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) by 20 percent.
The California Department of Public Health has issued All Facilities Letter 19-01 reminding hospitals of the new law requiring that they try to coordinate homeless patients’ discharge to appropriate area shelters or other community-based services. To help hospitals comply with the law, CHA has developed a guidebook titled Discharge Planning for Homeless Patients.
The California Department of Public Health reminds health care providers that, effective Jan. 1, they must make plant-based meal options — without meat, poultry, fish, dairy or eggs — available to patients, in accordance with their physician’s orders. For more information about the law, see page 15 of CHA’s 2018 Report on Legislation.
The Centers for Disease Control and Prevention has updated its health alert addressing a multistate outbreak of coagulopathy — a bleeding disorder that impacts the way blood clots — that has been linked to synthetic cannabinoid use.